These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 22210189

  • 1. Phosphorylation of Akt/GSK-3β/eNOS amplifies 5-HT2B receptor blockade mediated anti-hypertrophic effect in rats.
    Bharti S, Singh R, Chauhan SS, Hussain T, Al-Attas OS, Arya DS.
    FEBS Lett; 2012 Jan 20; 586(2):180-5. PubMed ID: 22210189
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Anti-hypertrophic effect of NHE-1 inhibition involves GSK-3beta-dependent attenuation of mitochondrial dysfunction.
    Javadov S, Rajapurohitam V, Kilić A, Zeidan A, Choi A, Karmazyn M.
    J Mol Cell Cardiol; 2009 Jun 20; 46(6):998-1007. PubMed ID: 19318234
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Curcumin protects against regional myocardial ischemia/reperfusion injury through activation of RISK/GSK-3β and inhibition of p38 MAPK and JNK.
    Jeong CW, Yoo KY, Lee SH, Jeong HJ, Lee CS, Kim SJ.
    J Cardiovasc Pharmacol Ther; 2012 Dec 20; 17(4):387-94. PubMed ID: 22396328
    [Abstract] [Full Text] [Related]

  • 7. Phosphorylation of eukaryotic translation initiation factor 2Bepsilon by glycogen synthase kinase-3beta regulates beta-adrenergic cardiac myocyte hypertrophy.
    Hardt SE, Tomita H, Katus HA, Sadoshima J.
    Circ Res; 2004 Apr 16; 94(7):926-35. PubMed ID: 15001529
    [Abstract] [Full Text] [Related]

  • 8. Urocortin-induced cardiomyocytes hypertrophy is associated with regulation of the GSK-3β pathway.
    Gruson D, Ginion A, Decroly N, Lause P, Vanoverschelde JL, Ketelslegers JM, Bertrand L, Thissen JP.
    Heart Vessels; 2012 Mar 16; 27(2):202-7. PubMed ID: 21505854
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3beta pathway.
    Palfi A, Toth A, Hanto K, Deres P, Szabados E, Szereday Z, Kulcsar G, Kalai T, Hideg K, Gallyas F, Sumegi B, Toth K, Halmosi R.
    J Mol Cell Cardiol; 2006 Jul 16; 41(1):149-59. PubMed ID: 16716347
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Glycogen synthase kinase-3 beta inhibitor suppresses Porphyromonas gingivalis lipopolysaccharide-induced CD40 expression by inhibiting nuclear factor-kappa B activation in mouse osteoblasts.
    Die L, Yan P, Jun Jiang Z, Min Hua T, Cai W, Xing L.
    Mol Immunol; 2012 Aug 16; 52(1):38-49. PubMed ID: 22580404
    [Abstract] [Full Text] [Related]

  • 13. Atorvastatin inhibits GSK-3beta phosphorylation by cardiac hypertrophic stimuli.
    Planavila A, Rodríguez-Calvo R, Palomer X, Coll T, Sánchez RM, Merlos M, Laguna JC, Vázquez-Carrera M.
    Biochim Biophys Acta; 2008 Aug 16; 1781(1-2):26-35. PubMed ID: 18036354
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tissue kallikrein promotes neovascularization and improves cardiac function by the Akt-glycogen synthase kinase-3beta pathway.
    Yao YY, Yin H, Shen B, Smith RS, Liu Y, Gao L, Chao L, Chao J.
    Cardiovasc Res; 2008 Dec 01; 80(3):354-64. PubMed ID: 18689794
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.